Global Companion Diagnostics Market By Product Type (Assays, Kits, & Reagents, Software & Services, and Instruments & Systems), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Magnetic Resonance Imaging (MRI), In Situ Hybridization (ISH), Immunohistochemistry (IHC), and Others), By Application (Oncology, Neurological Disorders, Infectious Diseases, Cardiovascular Diseases, and Others), By Sample Type (Tissue Samples, Blood Samples, and Others), By End-User (Academic & Research Centers, Reference Laboratories, Pharmaceutical & Biotechnology Companies, Hospitals & Physician Laboratories, CROs, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
  • 1.8. Industry Voices
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Companion Diagnostics Market Trends
  • 2.3. Technology Landscape
  • 2.4. Regulatory Framework
  • 2.5. Sustainability and ESG (Environmental, Social, Governance)
  • 2.6. Opportunity Map Analysis
  • 2.7. Opportunity Orbits
  • 2.8. PESTLE Analysis
  • 2.9. PORTER’S Five Force Analysis
  • 2.10. Drivers & Restraints Impact Analysis
  • 2.11. Value Chain Analysis
    • 2.11.1. List of Raw Materials Suppliers
    • 2.11.2. List of Companion Diagnostics Manufacturers
    • 2.11.3. List of Dealer/Distributors
  • 2.12. Regional Market Share and BPS Analysis
  • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Companion Diagnostics Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 3.3. Global Companion Diagnostics Market Attractiveness Analysis, By Product Type
    • 3.3.1. Assays, kits, & reagents
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Software & services
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
    • 3.3.3. Instruments & systems
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
  • 3.4. Global Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  • 3.5. Global Companion Diagnostics Market Attractiveness Analysis, By Technology
    • 3.5.1. Polymerase chain reaction (PCR)
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Next-generation sequencing (NGS)
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Magnetic resonance imaging (MRI)
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
    • 3.5.4. In situ hybridization (ISH)
      • 3.5.4.1. Insights
      • 3.5.4.2. Key Takeaways
    • 3.5.5. Immunohistochemistry (IHC)
      • 3.5.5.1. Insights
      • 3.5.5.2. Key Takeaways
    • 3.5.6. Others
      • 3.5.6.1. Insights
      • 3.5.6.2. Key Takeaways
  • 3.6. Global Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 3.7. Global Companion Diagnostics Market Attractiveness Analysis, By Application
    • 3.7.1. Oncology
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Neurological disorders
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Infectious diseases
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
    • 3.7.4. Cardiovascular diseases
      • 3.7.4.1. Insights
      • 3.7.4.2. Key Takeaways
    • 3.7.5. Others
      • • 3.7.5.1. Insights
        • 3.7.5.2. Key Takeaways
    • 3.8. Global Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
  • 3.9. Global Companion Diagnostics Market Attractiveness Analysis, By Sample Type
    • 3.9.1. Tissue samples
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Blood samples
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
    • 3.9.3. Others
      • 3.9.3.1. Insights
      • 3.9.3.2. Key Takeaways
  • 3.10. Global Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 3.11. Global Companion Diagnostics Market Attractiveness Analysis, By End-User
    • 3.11.1. Academic & research centers
      • 3.11.1.1. Insights
      • 3.11.1.2. Key Takeaways
    • 3.11.2. Reference laboratories
      • 3.11.2.1. Insights
      • 3.11.2.2. Key Takeaways
    • 3.11.3. Pharmaceutical & biotechnology companies
      • 3.11.3.1. Insights
      • 3.11.3.2. Key Takeaways
    • 3.11.4. Hospitals & physician laboratories
      • 3.11.4.1. Insights
      • 3.11.4.2. Key Takeaways
    • 3.11.5. CROs
      • 3.11.5.1. Insights
      • 3.11.5.2. Key Takeaways
    • 3.11.6. Others
      • 3.11.6.1. Insights
      • 3.11.6.2. Key Takeaways
• 4. Global Companion Diagnostics Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Companion Diagnostics Market Attractiveness Analysis, By Region
• 5. North America Companion Diagnostics Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 5.3. North America Companion Diagnostics Market Attractiveness Analysis, By Product Type
  • 5.4. North America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  • 5.5. North America Companion Diagnostics Market Attractiveness Analysis, By Technology
  • 5.6. North America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 5.7. North America Companion Diagnostics Market Attractiveness Analysis, By Application
  • 5.8. North America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
  • 5.9. North America Companion Diagnostics Market Attractiveness Analysis, By Sample Type
  • 5.10. North America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 5.11. North America Companion Diagnostics Market Attractiveness Analysis, By End-User
  • 5.12. North America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.13. North America Companion Diagnostics Market Attractiveness Analysis, By Country
    • 5.13.1. The US
    • 5.13.2. Canada
• 6. Europe Companion Diagnostics Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 6.3. Europe Companion Diagnostics Market Attractiveness Analysis, By Product Type
  • 6.4. Europe Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  • 6.5. Europe Companion Diagnostics Market Attractiveness Analysis, By Technology
  • 6.6. Europe Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 6.7. Europe Companion Diagnostics Market Attractiveness Analysis, By Application
  • 6.8. Europe Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
  • 6.9. Europe Companion Diagnostics Market Attractiveness Analysis, By Sample Type
  • 6.10. Europe Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 6.11. Europe Companion Diagnostics Market Attractiveness Analysis, By End-User
  • 6.12. Europe Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.13. Europe Companion Diagnostics Market Attractiveness Analysis, By Country
    • 6.13.1. Germany
    • 6.13.2. The UK
    • 6.13.3. France
    • 6.13.4. Spain
    • 6.13.5. Italy
    • 6.13.6. Russia
    • 6.13.7. Netherland
    • 6.13.8. Rest of Europe
• 7. Asia Pacific Companion Diagnostics Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 7.3. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Product Type
  • 7.4. Asia Pacific Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  • 7.5. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Technology
  • 7.6. Asia Pacific Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 7.7. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Application
  • 7.8. Asia Pacific Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
  • 7.9. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Sample Type
  • 7.10. Asia Pacific Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 7.11. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By End-User
  • 7.12. Asia Pacific Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.13. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Country
    • 7.13.1. China
    • 7.13.2. Japan
    • 7.13.3. South Korea
    • 7.13.4. India
    • 7.13.5. Australia
    • 7.13.6. New Zealand
    • 7.13.7. Singapore
    • 7.13.8. Thailand
    • 7.13.9. Vietnam
    • 7.13.10. Rest of Asia Pacific
• 8. Latin America Companion Diagnostics Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 8.3. Latin America Companion Diagnostics Market Attractiveness Analysis, By Product Type
  • 8.4. Latin America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  • 8.5. Latin America Companion Diagnostics Market Attractiveness Analysis, By Technology
  • 8.6. Latin America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 8.7. Latin America Companion Diagnostics Market Attractiveness Analysis, By Application
  • 8.8. Latin America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
  • 8.9. Latin America Companion Diagnostics Market Attractiveness Analysis, By Sample Type
  • 8.10. Latin America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 8.11. Latin America Companion Diagnostics Market Attractiveness Analysis, By End-User
  • 8.12. Latin America Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.13. Latin America Companion Diagnostics Market Attractiveness Analysis, By Country
    • 8.13.1. Brazil
    • 8.13.2. Mexico
    • 8.13.3. Rest of Latin America
• 9. Middle East & Africa Companion Diagnostics Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 9.3. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Product Type
  • 9.4. Middle East & Africa Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  • 9.5. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Technology
  • 9.6. Middle East & Africa Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 9.7. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Application
  • 9.8. Middle East & Africa Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
  • 9.9. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Sample Type
  • 9.10. Middle East & Africa Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 9.11. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By End-User
  • 9.12. Middle East & Africa Companion Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.13. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Country
    • 9.13.1. South Africa
    • 9.13.2. Saudi Arabia
    • 9.13.3. UAE
    • 9.13.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Thermo Fisher Scientific, Inc.
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. QIAGEN
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Myriad Genetics
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Illumina, Inc
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Guardant Health
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. Foundation Medicine
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. F. Hoffmann La Roche Ltd
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Agilent Technologies, Inc
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
    • 10.7.9. Abbott
      • 10.7.9.1. Company Details
      • 10.7.9.2. Business Overview
      • 10.7.9.3. Product Portfolio
      • 10.7.9.4. Financial Insights
      • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.9.6. SWOT Analysis
      • 10.7.9.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 2. Global Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 3. Global Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 4. Global Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 5. Global Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 6. Global Companion Diagnostics Market Value (US$ Mn), By Region, 2020-2034
• Table 7. North America Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 8. North America Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 9. North America Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 10. North America Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 11. North America Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 12. North America Companion Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 13. The US Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 14. The US Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 15. The US Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 16. The US Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 17. The US Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 18. Canada Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 19. Canada Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 20. Canada Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 21. Canada Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 22. Canada Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 23. Europe Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 24. Europe Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 25. Europe Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 26. Europe Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 27. Europe Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 28. Europe Companion Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 29. Germany Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 30. Germany Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 31. Germany Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 32. Germany Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 33. Germany Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 34. The UK Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 35. The UK Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 36. The UK Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 37. The UK Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 38. The UK Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 39. France Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 40. France Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 41. France Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 42. France Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 43. France Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 44. Spain Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 45. Spain Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 46. Spain Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 47. Spain Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 48. Spain Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 49. Italy Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 50. Italy Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 51. Italy Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 52. Italy Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 53. Italy Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 54. Russia Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 55. Russia Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 56. Russia Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 57. Russia Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 58. Russia Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 59. Netherland Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 60. Netherland Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 61. Netherland Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 62. Netherland Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 63. Netherland Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 64. Rest of Europe Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 65. Rest of Europe Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 66. Rest of Europe Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 67. Rest of Europe Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 68. Rest of Europe Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 69. Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 70. Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 71. Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 72. Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 73. Asia Pacific Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 74. Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 75. China Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 76. China Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 77. China Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 78. China Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 79. China Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 80. India Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 81. India Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 82. India Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 83. India Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 84. India Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 85. Japan Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 86. Japan Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 87. Japan Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 88. Japan Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 89. Japan Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 90. South Korea Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 91. South Korea Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 92. South Korea Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 93. South Korea Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 94. South Korea Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 95. Australia Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 96. Australia Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 97. Australia Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 98. Australia Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 99. Australia Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 100. New Zealand Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 101. New Zealand Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 102. New Zealand Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 103. New Zealand Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 104. New Zealand Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 105. Singapore Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 106. Singapore Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 107. Singapore Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 108. Singapore Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 109. Singapore Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 110. Thailand Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 111. Thailand Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 112. Thailand Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 113. Thailand Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 114. Thailand Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 115. Vietnam Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 116. Vietnam Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 117. Vietnam Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 118. Vietnam Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 119. Vietnam Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 120. Rest of Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 121. Rest of Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 122. Rest of Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 123. Rest of Asia Pacific Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 124. Rest of Asia Pacific Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 125. Latin America Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 126. Latin America Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 127. Latin America Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 128. Latin America Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 129. Latin America Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 130. Latin America Companion Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 131. Brazil Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 132. Brazil Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 133. Brazil Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 134. Brazil Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 135. Brazil Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 136. Mexico Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 137. Mexico Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 138. Mexico Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 139. Mexico Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 140. Mexico Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 141. Rest of Latin America Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 142. Rest of Latin America Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 143. Rest of Latin America Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 144. Rest of Latin America Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 145. Rest of Latin America Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 146. Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 147. Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 148. Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 149. Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 150. Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 151. Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 152. South Africa Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 153. South Africa Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 154. South Africa Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 155. South Africa Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 156. South Africa Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 157. Saudi Arabia Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 158. Saudi Arabia Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 159. Saudi Arabia Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 160. Saudi Arabia Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 161. Saudi Arabia Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 162. UAE Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 163. UAE Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 164. UAE Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 165. UAE Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 166. UAE Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
• Table 167. Rest of Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 168. Rest of Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
• Table 169. Rest of Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 170. Rest of Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 171. Rest of Middle East & Africa Companion Diagnostics Market Value (US$ Mn), By End-User, 2020-2034

List of Figures

• Figure 1. Global Companion Diagnostics Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Companion Diagnostics Market
• Figure 5. Global Companion Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 6. Global Companion Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 7. Global Companion Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
• Figure 8. Global Companion Diagnostics Market Attractiveness Analysis, By Technology
• Figure 9. Global Companion Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 10. Global Companion Diagnostics Market Attractiveness Analysis, By Application
• Figure 11. Global Companion Diagnostics Market Analysis, By Sample Type, 2020, 2024 and 2034
• Figure 12. Global Companion Diagnostics Market Attractiveness Analysis, By Sample Type
• Figure 13. Global Companion Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 14. Global Companion Diagnostics Market Attractiveness Analysis, By End-User
• Figure 15. Global Companion Diagnostics Market Analysis, By Region, 2020, 2024 and 2034
• Figure 16. Global Companion Diagnostics Market Attractiveness Analysis, By Region
• Figure 17. North America Companion Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 18. North America Companion Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 19. North America Companion Diagnostics Market (US$ Mn), by Assays, kits, & reagents, 2020-2034
• Figure 20. North America Companion Diagnostics Market (US$ Mn), by Software & services, 2020-2034
• Figure 21. North America Companion Diagnostics Market (US$ Mn), by Instruments & systems, 2020-2034
• Figure 22. North America Companion Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
• Figure 23. North America Companion Diagnostics Market Attractiveness Analysis, By Technology
• Figure 24. North America Companion Diagnostics Market (US$ Mn), by Polymerase chain reaction (PCR), 2020-2034
• Figure 25. North America Companion Diagnostics Market (US$ Mn), by Next-generation sequencing (NGS), 2020-2034
• Figure 26. North America Companion Diagnostics Market (US$ Mn), by Magnetic resonance imaging (MRI), 2020-2034
• Figure 27. North America Companion Diagnostics Market (US$ Mn), by In situ hybridization (ISH), 2020-2034
• Figure 28. North America Companion Diagnostics Market (US$ Mn), by Immunohistochemistry (IHC), 2020-2034
• Figure 29. North America Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 30. North America Companion Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 31. North America Companion Diagnostics Market Attractiveness Analysis, By Application
• Figure 32. North America Companion Diagnostics Market (US$ Mn), by Oncology, 2020-2034
• Figure 33. North America Companion Diagnostics Market (US$ Mn), by Neurological disorders, 2020-2034
• Figure 34. North America Companion Diagnostics Market (US$ Mn), by Infectious diseases, 2020-2034
• Figure 35. North America Companion Diagnostics Market (US$ Mn), by Cardiovascular diseases, 2020-2034
• Figure 36. North America Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 37. North America Companion Diagnostics Market Analysis, By Sample Type, 2020, 2024 and 2034
• Figure 38. North America Companion Diagnostics Market Attractiveness Analysis, By Sample Type
• Figure 39. North America Companion Diagnostics Market (US$ Mn), by Tissue samples, 2020-2034
• Figure 40. North America Companion Diagnostics Market (US$ Mn), by Blood samples, 2020-2034
• Figure 41. North America Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 42. North America Companion Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 43. North America Companion Diagnostics Market Attractiveness Analysis, By End-User
• Figure 44. North America Companion Diagnostics Market (US$ Mn), by Academic & research centers, 2020-2034
• Figure 45. North America Companion Diagnostics Market (US$ Mn), by Reference laboratories, 2020-2034
• Figure 46. North America Companion Diagnostics Market (US$ Mn), by Pharmaceutical & biotechnology companies, 2020-2034
• Figure 47. North America Companion Diagnostics Market (US$ Mn), by Hospitals & physician laboratories, 2020-2034
• Figure 48. North America Companion Diagnostics Market (US$ Mn), by CROs, 2020-2034
• Figure 49. North America Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 50. North America Companion Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 51. North America Companion Diagnostics Market Attractiveness Analysis, By Country
• Figure 52. Europe Companion Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 53. Europe Companion Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 54. Europe Companion Diagnostics Market (US$ Mn), by Assays, kits, & reagents, 2020-2034
• Figure 55. Europe Companion Diagnostics Market (US$ Mn), by Software & services, 2020-2034
• Figure 56. Europe Companion Diagnostics Market (US$ Mn), by Instruments & systems, 2020-2034
• Figure 57. Europe Companion Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
• Figure 58. Europe Companion Diagnostics Market Attractiveness Analysis, By Technology
• Figure 59. Europe Companion Diagnostics Market (US$ Mn), by Polymerase chain reaction (PCR), 2020-2034
• Figure 60. Europe Companion Diagnostics Market (US$ Mn), by Next-generation sequencing (NGS), 2020-2034
• Figure 61. Europe Companion Diagnostics Market (US$ Mn), by Magnetic resonance imaging (MRI), 2020-2034
• Figure 62. Europe Companion Diagnostics Market (US$ Mn), by In situ hybridization (ISH), 2020-2034
• Figure 63. Europe Companion Diagnostics Market (US$ Mn), by Immunohistochemistry (IHC), 2020-2034
• Figure 64. Europe Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 65. Europe Companion Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 66. Europe Companion Diagnostics Market Attractiveness Analysis, By Application
• Figure 67. Europe Companion Diagnostics Market (US$ Mn), by Oncology, 2020-2034
• Figure 68. Europe Companion Diagnostics Market (US$ Mn), by Neurological disorders, 2020-2034
• Figure 69. Europe Companion Diagnostics Market (US$ Mn), by Infectious diseases, 2020-2034
• Figure 70. Europe Companion Diagnostics Market (US$ Mn), by Cardiovascular diseases, 2020-2034
• Figure 71. Europe Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 72. Europe Companion Diagnostics Market Analysis, By Sample Type, 2020, 2024 and 2034
• Figure 73. Europe Companion Diagnostics Market Attractiveness Analysis, By Sample Type
• Figure 74. Europe Companion Diagnostics Market (US$ Mn), by Tissue samples, 2020-2034
• Figure 75. Europe Companion Diagnostics Market (US$ Mn), by Blood samples, 2020-2034
• Figure 76. Europe Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 77. Europe Companion Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 78. Europe Companion Diagnostics Market Attractiveness Analysis, By End-User
• Figure 79. Europe Companion Diagnostics Market (US$ Mn), by Academic & research centers, 2020-2034
• Figure 80. Europe Companion Diagnostics Market (US$ Mn), by Reference laboratories, 2020-2034
• Figure 81. Europe Companion Diagnostics Market (US$ Mn), by Pharmaceutical & biotechnology companies, 2020-2034
• Figure 82. Europe Companion Diagnostics Market (US$ Mn), by Hospitals & physician laboratories, 2020-2034
• Figure 83. Europe Companion Diagnostics Market (US$ Mn), by CROs, 2020-2034
• Figure 84. Europe Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 85. Europe Companion Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 86. Europe Companion Diagnostics Market Attractiveness Analysis, By Country
• Figure 87. Asia Pacific Companion Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 88. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 89. Asia Pacific Companion Diagnostics Market (US$ Mn), by Assays, kits, & reagents, 2020-2034
• Figure 90. Asia Pacific Companion Diagnostics Market (US$ Mn), by Software & services, 2020-2034
• Figure 91. Asia Pacific Companion Diagnostics Market (US$ Mn), by Instruments & systems, 2020-2034
• Figure 92. Asia Pacific Companion Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
• Figure 93. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Technology
• Figure 94. Asia Pacific Companion Diagnostics Market (US$ Mn), by Polymerase chain reaction (PCR), 2020-2034
• Figure 95. Asia Pacific Companion Diagnostics Market (US$ Mn), by Next-generation sequencing (NGS), 2020-2034
• Figure 96. Asia Pacific Companion Diagnostics Market (US$ Mn), by Magnetic resonance imaging (MRI), 2020-2034
• Figure 97. Asia Pacific Companion Diagnostics Market (US$ Mn), by In situ hybridization (ISH), 2020-2034
• Figure 98. Asia Pacific Companion Diagnostics Market (US$ Mn), by Immunohistochemistry (IHC), 2020-2034
• Figure 99. Asia Pacific Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 100. Asia Pacific Companion Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 101. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Application
• Figure 102. Asia Pacific Companion Diagnostics Market (US$ Mn), by Oncology, 2020-2034
• Figure 103. Asia Pacific Companion Diagnostics Market (US$ Mn), by Neurological disorders, 2020-2034
• Figure 104. Asia Pacific Companion Diagnostics Market (US$ Mn), by Infectious diseases, 2020-2034
• Figure 105. Asia Pacific Companion Diagnostics Market (US$ Mn), by Cardiovascular diseases, 2020-2034
• Figure 106. Asia Pacific Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 107. Asia Pacific Companion Diagnostics Market Analysis, By Sample Type, 2020, 2024 and 2034
• Figure 108. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Sample Type
• Figure 109. Asia Pacific Companion Diagnostics Market (US$ Mn), by Tissue samples, 2020-2034
• Figure 110. Asia Pacific Companion Diagnostics Market (US$ Mn), by Blood samples, 2020-2034
• Figure 111. Asia Pacific Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 112. Asia Pacific Companion Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 113. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By End-User
• Figure 114. Asia Pacific Companion Diagnostics Market (US$ Mn), by Academic & research centers, 2020-2034
• Figure 115. Asia Pacific Companion Diagnostics Market (US$ Mn), by Reference laboratories, 2020-2034
• Figure 116. Asia Pacific Companion Diagnostics Market (US$ Mn), by Pharmaceutical & biotechnology companies, 2020-2034
• Figure 117. Asia Pacific Companion Diagnostics Market (US$ Mn), by Hospitals & physician laboratories, 2020-2034
• Figure 118. Asia Pacific Companion Diagnostics Market (US$ Mn), by CROs, 2020-2034
• Figure 119. Asia Pacific Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 120. Asia Pacific Companion Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 121. Asia Pacific Companion Diagnostics Market Attractiveness Analysis, By Country
• Figure 122. Latin America Companion Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 123. Latin America Companion Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 124. Latin America Companion Diagnostics Market (US$ Mn), by Assays, kits, & reagents, 2020-2034
• Figure 125. Latin America Companion Diagnostics Market (US$ Mn), by Software & services, 2020-2034
• Figure 126. Latin America Companion Diagnostics Market (US$ Mn), by Instruments & systems, 2020-2034
• Figure 127. Latin America Companion Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
• Figure 128. Latin America Companion Diagnostics Market Attractiveness Analysis, By Technology
• Figure 129. Latin America Companion Diagnostics Market (US$ Mn), by Polymerase chain reaction (PCR), 2020-2034
• Figure 130. Latin America Companion Diagnostics Market (US$ Mn), by Next-generation sequencing (NGS), 2020-2034
• Figure 131. Latin America Companion Diagnostics Market (US$ Mn), by Magnetic resonance imaging (MRI), 2020-2034
• Figure 132. Latin America Companion Diagnostics Market (US$ Mn), by In situ hybridization (ISH), 2020-2034
• Figure 133. Latin America Companion Diagnostics Market (US$ Mn), by Immunohistochemistry (IHC), 2020-2034
• Figure 134. Latin America Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 135. Latin America Companion Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 136. Latin America Companion Diagnostics Market Attractiveness Analysis, By Application
• Figure 137. Latin America Companion Diagnostics Market (US$ Mn), by Oncology, 2020-2034
• Figure 138. Latin America Companion Diagnostics Market (US$ Mn), by Neurological disorders, 2020-2034
• Figure 139. Latin America Companion Diagnostics Market (US$ Mn), by Infectious diseases, 2020-2034
• Figure 140. Latin America Companion Diagnostics Market (US$ Mn), by Cardiovascular diseases, 2020-2034
• Figure 141. Latin America Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 142. Latin America Companion Diagnostics Market Analysis, By Sample Type, 2020, 2024 and 2034
• Figure 143. Latin America Companion Diagnostics Market Attractiveness Analysis, By Sample Type
• Figure 144. Latin America Companion Diagnostics Market (US$ Mn), by Tissue samples, 2020-2034
• Figure 145. Latin America Companion Diagnostics Market (US$ Mn), by Blood samples, 2020-2034
• Figure 146. Latin America Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 147. Latin America Companion Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 148. Latin America Companion Diagnostics Market Attractiveness Analysis, By End-User
• Figure 149. Latin America Companion Diagnostics Market (US$ Mn), by Academic & research centers, 2020-2034
• Figure 150. Latin America Companion Diagnostics Market (US$ Mn), by Reference laboratories, 2020-2034
• Figure 151. Latin America Companion Diagnostics Market (US$ Mn), by Pharmaceutical & biotechnology companies, 2020-2034
• Figure 152. Latin America Companion Diagnostics Market (US$ Mn), by Hospitals & physician laboratories, 2020-2034
• Figure 153. Latin America Companion Diagnostics Market (US$ Mn), by CROs, 2020-2034
• Figure 154. Latin America Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 155. Latin America Companion Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 156. Latin America Companion Diagnostics Market Attractiveness Analysis, By Country
• Figure 157. Middle East & Africa Companion Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 158. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 159. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Assays, kits, & reagents, 2020-2034
• Figure 160. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Software & services, 2020-2034
• Figure 161. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Instruments & systems, 2020-2034
• Figure 162. Middle East & Africa Companion Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
• Figure 163. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Technology
• Figure 164. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Polymerase chain reaction (PCR), 2020-2034
• Figure 165. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Next-generation sequencing (NGS), 2020-2034
• Figure 166. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Magnetic resonance imaging (MRI), 2020-2034
• Figure 167. Middle East & Africa Companion Diagnostics Market (US$ Mn), by In situ hybridization (ISH), 2020-2034
• Figure 168. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Immunohistochemistry (IHC), 2020-2034
• Figure 169. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 170. Middle East & Africa Companion Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 171. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Application
• Figure 172. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Oncology, 2020-2034
• Figure 173. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Neurological disorders, 2020-2034
• Figure 174. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Infectious diseases, 2020-2034
• Figure 175. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Cardiovascular diseases, 2020-2034
• Figure 176. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 177. Middle East & Africa Companion Diagnostics Market Analysis, By Sample Type, 2020, 2024 and 2034
• Figure 178. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Sample Type
• Figure 179. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Tissue samples, 2020-2034
• Figure 180. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Blood samples, 2020-2034
• Figure 181. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 182. Middle East & Africa Companion Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 183. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By End-User
• Figure 184. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Academic & research centers, 2020-2034
• Figure 185. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Reference laboratories, 2020-2034
• Figure 186. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Pharmaceutical & biotechnology companies, 2020-2034
• Figure 187. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Hospitals & physician laboratories, 2020-2034
• Figure 188. Middle East & Africa Companion Diagnostics Market (US$ Mn), by CROs, 2020-2034
• Figure 189. Middle East & Africa Companion Diagnostics Market (US$ Mn), by Others, 2020-2034
• Figure 190. Middle East & Africa Companion Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 191. Middle East & Africa Companion Diagnostics Market Attractiveness Analysis, By Country